miR-342-3p对乳腺癌化疗敏感性的影响
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

无锡市卫生局科研项目计划资助(ML201307)


miR-342-3p influences the chemotherapy sensitivity of breast cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:研究miR-342-3p对乳腺癌化疗敏感性的影响-方法:检测乳腺癌细胞株MCF-7-SKBr3和MDA-MB-231中miR-342-3p的表达-应用脂质体转染方法,转染hsa-miR-342-3p模拟物到低表达miR-342-3p的乳腺癌细胞株(mimic转染组),同时设立阴性对照(mim-NC转染组);转染miR-342-3p抑制物到高表达miR-342-3p的乳腺癌细胞株(inhibitor转染组),同时设立阴性对照(inhi-NC转染组)-mimic转染组-mim-NC转染组-inhibitor转染组和inhi-NC转染组细胞,分别加入浓度为2 -滋mol/L的紫杉醇-顺铂及4 -滋mol/L的阿霉素的进行培养,应用CCK8法检测药物作用48 h后细胞增殖率的变化-结果:以SKBr3为参照,miR-243-3p在MCF-7细胞中的相对表达倍数是126.000,在MDA-MB-231细胞中的相对表达倍数是0.017-mimic转染组细胞与紫杉醇-顺铂孵育48 h后,肿瘤细胞增殖率低于mim-NC转染组,差异有统计学意义(P < 0.05),但与阿霉素孵育后细胞增殖率与mim-NC转染组差异无统计学意义(P > 0.05);inhibitor转染组细胞与紫杉醇-顺铂和阿霉素孵育48 h后,肿瘤细胞的增殖率高于inhi-NC转染组,差异有统计学意义(P < 0.05)-结论:miR-342-3p能调控乳腺癌细胞株MDA-MB-231-MCF-7对紫杉醇和顺铂的化疗敏感性,但提高miR-342-3p表达不能增加MDA-MB-231细胞对阿霉素的化疗敏感性,降低miR-342-3p的表达却可以减弱MCF-7细胞对阿霉素的化疗敏感性-

    Abstract:

    Objective:To explore the effect of miR-342-3p on chemotherapy sensitivity of breast cancer cells. Methods:The expression levels of miR-342-3p were detected in breast cancer cell lines MCF-7,SKBr3 and MDA-MB-231. By using lipofectamine,the hsa-miR-342-3p mimic was transfected into breast cancer cell lines,which were of the lowest expression of miR-342-3p cell lines (the mimic group). The mim-NC was performed as the negative control group. Furthermore,the miR-342-3p inhibitor was transfected into breast cancer cell lines of the highest expression of miR-342-3p,the inhi-NC was performed as the negative control group. Cells from four different groups (the mimic,mim-NC,inhibitor and inhi-NC groups) were treated with 2 -滋mol/L paclitaxel,2 -滋mol/L cisplatin and 4 -滋mol/L doxorubicine for 48 hours,respectively. CCK8 assay was used for detection of cell proliferation. Results:Compared with the expression level of miR-243-3p in SKBr3,the level of miR-243-3p in MCF-7 cells was significantly increased (126.000 fold change),but it was decreased (0.017 fold change) in MDA-MB-231 cell lines. The rates of cell proliferation in the mimic group after treatment with paclitaxel and cisplatin for 48 hours were significantly lower than those in the mim-NC group,respectively (P < 0.05,respectively). However,the cell proliferation rates in the mimic group and the mim-NC group after treatment with doxorubicine for 48 hours had no significant difference (P > 0.05). The cell proliferation rates in the inhibitor group were significantly higher than those in the inhi-NC groups after treatment with paclitaxel,cisplatin and doxorubicine for 48 hours,respectively (P < 0.05,respectively). Conclusion:miR-342-3p may play a key role in the regulation of chemotherapy sensitivity to paclitaxel and cisplatin in breast cancer cell lines MDA-MB-231 and MCF-7. Up-regulation of miR-342-3p expression could not increase the chemotherapy sensitivity to doxorubicine,but down-regulation of miR-342-3p expression may weaken the chemotherapy sensitivity to doxorubicine.

    参考文献
    相似文献
    引证文献
引用本文

马 涛,张君莹,吴建中,唐金海. miR-342-3p对乳腺癌化疗敏感性的影响[J].南京医科大学学报(自然科学版),2014,(6):716-720

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-01-14
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-06-19
  • 出版日期:
通知关闭
郑重声明